Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways
2004
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
Fibrosing connective tissue disorders of the skin: Molecular similarities and distinctions
2013
Fibrosis in Systemic Sclerosis
2008
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
Rheumatoid arthritis
2018 Standout
Cellular and molecular mechanisms of fibrosis
2007 Standout
Interleukin-17 Family Members and Inflammation
2004 Standout
Neutrophils at work
2014 Standout
Anti-tumour necrosis factor α therapy in rheumatoid arthritis: an update on safety
2004
Risk of Mycobacterial Infections Associated With Rheumatoid Arthritis in Ontario, Canada
2014
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
2015
Mechanotransduction and extracellular matrix homeostasis
2014 Standout
Degenerative Cervical Myelopathy
2015 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Systemic sclerosis
2017 Standout
Active-comparator design and new-user design in observational studies
2015
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Five Years of GWAS Discovery
2012 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Scleroderma
2009 Standout
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
2011
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line
2003
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Systematic review: ulcer definition in NSAID ulcer prevention trials
2008
Progress in the genetics of ankylosing spondylitis
2011
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Recent advances in fibroblast signaling and biology in scleroderma
2004
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression
2015
Modulation of Prosurvival Signaling in Fibroblasts by a Protein Kinase Inhibitor Protects against Fibrotic Tissue Injury
2005
SLE and Infections
2003
Systemic amyloidosis
2015 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
TLR9 as a key receptor for the recognition of DNA☆
2008
Adult haemophagocytic syndrome
2013
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Positive association of HLA‐DRB1*15 with keloid disease in Caucasians
2008
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
2009
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
2009
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
Hallmarks of Cellular Senescence
2018 Standout
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Colistin: an update on the antibiotic of the 21st century
2012
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
2018
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
2010
Scleroderma: from cell and molecular mechanisms to disease models
2005
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Homozygosity for DNASE2 single nucleotide polymorphisms in the 5′-regulatory region is associated with rheumatoid arthritis
2008
Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor
2004
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
2010 Standout
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
2018
Recent Developments in Myofibroblast Biology
2012
The Pathobiology of Vascular Dementia
2013 Standout
The anti-inflammatory effect of A3adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis
2007
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Increased levels of transforming growth factor β receptor type I and up‐regulation of matrix gene program: A model of scleroderma
2006
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The Myofibroblast
2007 Standout
Systemic AA Amyloidosis
2012
Infections and SLE
2005
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
2009 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
2012
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Living Beyond Our Physiological Means
2009
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions
2004
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors
2008
Genetic and epigenetic abnormalities in systemic sclerosis
2016
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Association between helplessness, disability, and disease activity with health-related quality of life among rheumatoid arthritis patients in a multiethnic Asian population
2014
NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus
2012
The Inflammasomes: Guardians of the Body
2009 Standout
Wound Healing: A Cellular Perspective
2018 Standout
MOF–Thermogel Composites for Differentiated and Sustained Dual Drug Delivery
2023 StandoutNobel
Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
2015
Prosthetic Joint Infection
2014 Standout
Caffeine and Its Antioxidant Properties—It Is All about Dose and Source
2022
Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach
2005
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Works of Jae‐Bum Jun being referenced
Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
2004
Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-α Blocker in the Treatment of Rheumatic Diseases
2009
Necessary role of phosphatidylinositol 3‐kinase in transforming growth factor β–mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts
2002
DNase II polymorphisms associated with risk of renal disorder among systemic lupus erythematosus patients
2005
Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis
2017
Prevalence of ossification of the posterior longitudinal ligament of the cervical spine
2008
ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans
2009
Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY
2007
Scleroderma Fibroblasts Demonstrate Enhanced Activation of Akt (Protein Kinase B) In Situ
2005
Association between the HLA‐DRB1 gene and clinical features of systemic sclerosis in Korea
2006
Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
2010
Effects of coffee consumption on serum uric acid: systematic review and meta-analysis
2016
Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA)
2012
Fibroblast and endothelial apoptosis in systemic sclerosis
2003
Adult-onset Still's Disease with Disseminated Intravascular Coagulation and Multiple Organ Dysfunctions Dramatically Treated with Cyclosporine A
2004
Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis.
2001
The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea.
2003
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
2007